Synergistic antibiofilm efficacy of Undecanoic acid (cas 112-37-8) and auxins against quorum sensing mediated biofilm formation of luminescent Vibrio harveyi
-
Add time:08/20/2019 Source:sciencedirect.com
Vibrio harveyi are Gram-negative marine luminescent bacteria and most of them are multi-drug resistant pathogens. The incidence of biofilm mediated antibiotic resistance stresses the quest for novel therapeutics to treat luminescent vibriosis in aquaculture. This study intended to explore the combinatorial effect of Undecanoic acid (cas 112-37-8) (UDA) along with auxins ((Indole-3-Acetic Acid (IAA) and Indole-3-Butyric Acid (IBA)) against V. harveyi biofilm formation under in vitro and in vivo conditions. The minimal inhibitory concentration (MIC) of UDA against planktonic V. harveyi was found to be 20 μg/ml and for auxins it was 200 μg/ml. Furthermore, the synergism of both combinations was calculated through fractional inhibitory concentration (FIC). The FIC of UDA with auxins to inhibit biofilm formation was identified as 10 μg/ml for UDA along with 30 μg/ml of either IAA or IBA. Light and confocal laser scanning microscopic (CLSM) analyses further confirmed that these combinations effectively prevented the initial attachment, microcolonies and also dispersed the mature biofilm formation of V. harveyi. Similar results were obtained for bioluminescence, caseinase and swarming motility of V. harveyi, where UDA with IAA or IBA combinations reduced the bioluminescence by upto 93.6% and 76.7%, respectively. Besides, in support of in vitro results, the real-time PCR analysis of quorum sensing (QS) genes revealed the master regulators luxO, luxQ, luxR and luxS to be down-regulated upon treatment with these combinations in V. harveyi. Further in vivo studies using brine shrimp larvae also manifested the enhanced survival rate and reduced adherence of test pathogen upon treatment with these compounds.
We also recommend Trading Suppliers and Manufacturers of Undecanoic acid (cas 112-37-8). Pls Click Website Link as below: cas 112-37-8 suppliers
Prev:PaperDisaccharide production by glucoamylase in aqueous ether mixtures
Next:Investigations into the separation behaviour of perfluorinated C8 and Undecanoic acid (cas 112-37-8) modified silica hydride stationary phases) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and conformation of a bilirubin analog with propionic acid side chains extended to Undecanoic acid (cas 112-37-8)08/29/2019
- The adsorption of Undecanoic acid (cas 112-37-8) and non-adecanoic acid on oxidized and unoxidized copper crystals☆08/28/2019
- 68Ga labeled fatty acids for cardiac metabolic imaging: Influence of different bifunctional chelators08/27/2019
- The morphology of monolayers of three thioalkyl Undecanoic acid (cas 112-37-8)s at the air/water interface☆08/26/2019
- Synthesis and properties of 11-(3,5-Di-tert-butyl-2-hydroxyphenylcarbamoyl)Undecanoic acid (cas 112-37-8), a new amphiphilic antioxidant08/25/2019
- Amplified fluorescence quenching in Langmuir-Blodgett films of 11-(9-carbazolyl)Undecanoic acid (cas 112-37-8) and palmitic acid08/24/2019
- Inclusion complexes of V-amylose with Undecanoic acid (cas 112-37-8) and dodecanol at atomic resolution: X-ray structures with cycloamylose containing 26 d-glucoses (cyclohexaicosaose) as host08/23/2019
- A novel nanoscale resist using 10-Undecanoic acid (cas 112-37-8) monolayers on silicon dioxide08/22/2019
- Investigations into the separation behaviour of perfluorinated C8 and Undecanoic acid (cas 112-37-8) modified silica hydride stationary phases08/21/2019
-
Health and Chemical more >